Clinical

Pfizer’s Phase 3 Trial for Gene Therapy in Boys with Duchenne Muscular Dystrophy Fails to Show Functional Improvement

Pfizer's gene therapy for Duchenne muscular dystrophy failed to improve motor function in young boys in a key late-stage trial. The last evaluation of...

Phase 3 Trial Results for Loqtorzi Show Positive Results in Advanced Hepatocellular Carcinoma Patients

Phase 3 trial results for Loqtorzi (toripalimab) and Avastin (bevacizumab) show that in first-line patients suffering from advanced hepatocellular carcinoma (HCC), the combination therapy...

Boehringer’s Ingelheim’s Survodutide Shows Liver Fibrosis Improvement

Zealand Pharma has disclosed that Boehringer Ingelheim has published findings from a sub-analysis of a Phase 2 trial using survodutide, showing that after 48...

Merck-Moderna’s Cancer Vaccine Collaboration Yields Positive Results in Mid-Stage Follow-Up Study

In a follow-up study conducted on approximately 160 people, it was discovered that when used in combination with Merck’s cancer treatment Keytruda, Merck and...

Soterios Achieves Phase 2 Success for Alopecia Cream as an Alternative to JAK Inhibitors

Soterios Pharma plans to proceed to phase 3 trials after its 1% Alopecia areata cream successfully reduced the severity of the disease, achieving the...

J&J’s Antidepressant Shows Promising Sleep Results in Trial

Johnson & Johnson developed seltorexant as an orexin-2 antagonist to prevent excessive receptor stimulation that leads to hyperarousal. The drug specifically targets a protein...

Phase 3 Trial Results Show Datopotamab Deruxtecan Has Positive Outcomes in Lung Cancer Patients

When compared to docetaxel, the TROPION-Lung01 Phase III trial indicated that datopotamab deruxtecan (Dato-DXd) provided numerically better overall survival (OS) outcomes in patients with...

Neuren Phase 2 Study Shows Pitt Hopkins Syndrome Promise

Neuren Pharmaceuticals revealed key outcomes from its Phase 2 study of NNZ-2591 in kids with Pitt Hopkins syndrome (PTHS) today. Across four efficacy measures...

Latest news

Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort

California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms....

According to research, Gilead’s long-acting HIV medication is superior to Truvada

Gilead Sciences (GILD.O) announced that in a late-stage trial, its injectable treatment, lenacapavir, was 40.2% more effective in preventing...

Life Sciences Voice Top Five Newsletter

Welcome to the latest edition of the Life Sciences Voice Top Five Newsletter, your source for the top developments...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

FDA refuses to approve Regeneron’s blood cancer medication

Regeneron's hasty submission of the bispecific antibody odronextamab to...